Clinical Trials

500 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003788 2013-11-06

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Phase 3 Unknown

270 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002944 2013-09-09

Combination Chemotherapy in Treating Children With Progressive Brain Tumors

428 enrolled

Astrocytoma, Brain Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

NCT00003101 2013-06-25

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Phase 2 Completed

60 enrolled

Oligodendroglioma, Central Nervous System Neoplasms

NCT00004004 2013-06-21

Procarbazine in Treating Patients With Recurrent Brain Tumor

Phase 1/2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002463 2013-02-18

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors

Phase 2 Completed

4 enrolled

Astrocytoma, Central Nervous System Neoplasms

NCT00003293 2012-09-11

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002840 2012-07-10

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

350 enrolled

Phase EARLY_PHASE1 Withdrawn

Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

CNSLymphoid

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

NCT00003564 2012-02-22

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

Phase 3 Withdrawn